New autoantibodies and their clinical associations in juvenile myositis - A systematic review

Acta Reumatologica Portuguesa

Volumn 38, Issue 4, 2013, Pages 234-241

  Peixoto, Daniela ^a   Costa, José ^a   Ferretti, Marta ^b   Malattia, Clara ^b,c   Martini, Alberto ^b,c  

^a Hospital Conde de Bertiandos   (Portugal)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Juvenil idiopathic inflammatory myo pathies; Myositis specific antibodies; Novel auto antibodies

Indexed keywords

AUTOANTIBODY;

DERMATOMYOSITIS; HUMAN; IMMUNOLOGY;

AUTOANTIBODIES; DERMATOMYOSITIS; HUMANS;

EID: 84893473279     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Wedderburn LR. Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment. Best Practice & Research Clinical Rheumatology 2009; 665-678.
2. Rider LG, Miller FW. Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies. JAMA 2011; 305(2):183-190.
3. Mendez EP, Lipton R, Ramsey-Goldman R et al. NIAMS Juvenile DM Registry Physician Referral Group: US incidence of juvenile dermatomyositis, 1995-1998: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 2003;49:300-305.
4. Batthish M, Feldman BM. Juvenile dermatomyositis. Curr Rheumatol Rep 2011; 13(3):216-224.
5. Betteridge ZE, Gunawardena H, McHugh NJ. Novel autoantibodies and clinical phenotypes in adult and juvenile myositis. Arthritis Research & Therapy 2011; 13:209.
6. Tansley SL, McHugh NJ, Wedderburn LR. Adult and juvenile dermatomyositis: are the distinct clinical features explained by our current understanding of serological subgroups and patho -genic mechanisms? Arthritis Research & Therapy 2013; 15:211.
7. TargoffIN, Mamyrova G, Trieu EP et al. A novel autoantibody to a 155-kd protein is associated with dermatomyositis. Arthritis Rheum 2006; 54:3682-3689.
8. TargoffIN, Trieu EP, Levy-Neto M, Prasertsuntarsai T, Miller FW. Autoantibodies to transcriptional intermediary factor 1-gamma (TIF1-g) in dermatomyositis (abstract). Arthritis Rheum 2006, 54:S518.
9. Fugimoto M, Hamaguchi Y, Kaji K, et al. Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins. Arthritis Rheum. 2012; 64(2):513-522.
10. Gunawardena H, Wedderburn LR, North J, et.al. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology 2008; 47(3):324--328.
11. Espada G, Maldonado Cocco JA, Fertig N, Oddis CV. Clinical and serologic characterization of an argentine pediatric myositis cohort: identification of a novel autoantibody (anti-MJ) to a 142-kDa protein. J Rheumatol 2009; 36:2547-2551.
12. Shah M, Mamyrova G, TargoffIN, et al. The Clinical Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies. Medicine (Baltimore) 2013; 92(1):25-41.
13. Gunawardena H, Wedderburn LR, Chinoy H, et al. Juvenile Dermatomyositis Research Group, UK and Ireland: Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis. Arthritis Rheum 2009; 60:1807-1814.
14. Tansley S, Betteridge Z, Gunawardena H, et al. Clinical Differences Between Adult and Juvenile Dermatomyositis Associated with Anti-NXP2 autoantibodies. 2012 ACR (abstract).
15. TargoffIN, Trieu EP, Levy-Neto M, Fertig N, Oddis CV. Sera with autoantibodies to the MJ antigen react with NXP2. Arthritis Rheum 2007; 56:S787.
16. Sato S, Hirakata M, Kuwana M, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005; 52:1571-1576.
17. Kobayashi I, Okura Y, Yamada M, Kawamura N, Ariga T. Antimelanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis. J Pediatr 2011; 158(4):675-767.
18. Sato S, Kobayashi Yamazaki K, Suzuki Y. Clinical Utility of Anti-CADM-140/Melanoma Differentiation-Associated Gene 5 Autoantibody Titers in Patients with Juvenile Dermatomyositis and Rapidly Progressive Interstitial Lung Disease 2012 ACR (abstract)
19. Betteridge Z, Tansley S, Gunawardena H, et al. Clinical Phenotypes of Caucasian Adult and Juvenile Dermatomyositis Patients with Anti-MDA5 Autoantibodies. 2012 ACR (abstract).
20. Tarricone E, Ghirardello A, Rampudda M, Bassi N, Punzi L, Doria A. Anti-SAE antibodies in autoimmune myositis: Identification by unlabelled protein immunoprecipitation in an Italian patient cohort. Journal of Immunological Methods 2012; 384:128-134.
21. Betteridge ZE, Gunawardena H, Chinoy H, North J, Ollier WE, Cooper RG, McHugh NJ. UK Adult Onset Myositis Immunogenetic Collaboration: Clinical and HLA-class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK adult-onset Caucasian myositis. Ann Rheum Dis 2009; 68(10):1621-1625.
22. Fujimoto M, Matsushita T, Hamaguchi Y, et al. Autoantibodies to Small Ubiquitin-Like Modifier Activating Enzymes in Japanese Patients with Dermatomyositis. Ann Rheum Dis 2013; 72:151-153.
23. Muro Y, Sugiura K, Akiyama M. Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients. Autoimmunity 2012.
24. Christopher-Stine L, Casciola-Rosen LA, Hong G, et al. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum 2010; 62:2757-2766.
25. Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Casciola-Rosen LA. Autoantibodies against 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase (HMGCR) in Patients with Statin-Associated Autoimmune Myopathy. Arthritis Rheum 2011; 63(3):713-721.
26. Lowry CA, Pilkington CA. Juvenile dermatomyositis: extramuscular manifestations and their management. Curr Opin Rheumatol 2009;21(6):575-580.
27. Ghirardello A, Rampudda M, Ekholm L, et al. Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) 2010; 49:2370-2374.
28. Vencovsky J, Lundberg IE, Patterson E, et al. Myositis associated autoantibodies detected using a novel recombinant protein blotting: clinical associations. Ann Rheum Dis 2010; 69 (Suppl 3):425.